Enliven Therapeutics News

Enliven Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Hohl Benjamin

Dec 2 17:21 ET

Enliven Therapeutics | 144: Notice of proposed sale of securities pursuant to Rule 144

Nov 15 16:39 ET

Enliven Therapeutics | 144: Notice of proposed sale of securities pursuant to Rule 144

Nov 15 16:33 ET

Enliven Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-RA Capital Management, L.P.(2.2%),Peter Kolchinsky(2.2%), etc.

Nov 14 17:53 ET

Enliven Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Venrock Healthcare Capital Partners III, L.P.(8.5%),VHCP Co-Investment Holdings III, LLC(8.5%), etc.

Nov 14 17:51 ET

Enliven Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Citadel Advisors LLC(3.7%),Citadel Advisors Holdings LP(3.7%), etc.

Nov 14 16:29 ET

Enliven Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Fairmount Funds Management LLC(6.8%),Peter Harwin(6.8%), etc.

Nov 14 16:23 ET

Enliven Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Commodore Capital LP(8.7%),Commodore Capital Master LP(8.7%)

Nov 14 16:15 ET

Enliven Therapeutics | SC 13G: Statement of acquisition of beneficial ownership by individuals-Polar Capital Holdings Plc(5.69%),Polar Capital LLP(5.69%)

Nov 13 17:57 ET

Enliven Therapeutics | 10-Q: Q3 2024 Earnings Report

Nov 13 16:20 ET

Enliven Therapeutics | 8-K: Enliven Therapeutics Reports Third Quarter Financial Results and Provides a Business Update

Nov 13 16:16 ET

Enliven Therapeutics | SC 13G: Statement of acquisition of beneficial ownership by individuals-BlackRock, Inc.(6.2%)

Nov 8 14:26 ET

Enliven Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Hohl Benjamin

Oct 30 18:07 ET

Enliven Therapeutics | SC 13G: Statement of acquisition of beneficial ownership by individuals-BlackRock, Inc.(6.2%)

Oct 24 14:05 ET

Enliven Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Patel Anish

Oct 22 16:28 ET

Enliven Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Hohl Benjamin

Oct 22 16:24 ET

Enliven Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Kintz Samuel

Oct 22 16:24 ET

Enliven Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Lyssikatos Joseph P

Oct 22 16:24 ET

Enliven Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Heyman Richard A.

Oct 22 16:23 ET

Enliven Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Collins Helen Louise

Oct 22 16:19 ET